181 related articles for article (PubMed ID: 37164270)
1. Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report.
Andrade RJ; Aithal GP; de Boer YS; Liberal R; Gerbes A; Regev A; Terziroli Beretta-Piccoli B; Schramm C; Kleiner DE; De Martin E; Kullak-Ublick GA; Stirnimann G; Devarbhavi H; Vierling JM; Manns MP; Sebode M; Londoño MC; Avigan M; Robles-Diaz M; García-Cortes M; Atallah E; Heneghan M; Chalasani N; Trivedi PJ; Hayashi PH; Taubert R; Fontana RJ; Weber S; Oo YH; Zen Y; Licata A; Lucena MI; Mieli-Vergani G; Vergani D; Björnsson ES;
J Hepatol; 2023 Sep; 79(3):853-866. PubMed ID: 37164270
[TBL] [Abstract][Full Text] [Related]
2. Setting up criteria for drug-induced autoimmune-like hepatitis through a systematic analysis of published reports.
Björnsson ES; Medina-Caliz I; Andrade RJ; Lucena MI
Hepatol Commun; 2022 Aug; 6(8):1895-1909. PubMed ID: 35596597
[TBL] [Abstract][Full Text] [Related]
3. Relapse and Need for Extended Immunosuppression: Novel Features of Drug-Induced Autoimmune Hepatitis.
Weber S; Gerbes AL
Digestion; 2023; 104(3):243-248. PubMed ID: 36603570
[TBL] [Abstract][Full Text] [Related]
4. [Drug-induced autoimmune-like liver injury].
Weber S
Inn Med (Heidelb); 2024 Apr; 65(4):334-339. PubMed ID: 38374310
[TBL] [Abstract][Full Text] [Related]
5. Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury.
de Boer YS; Kosinski AS; Urban TJ; Zhao Z; Long N; Chalasani N; Kleiner DE; Hoofnagle JH;
Clin Gastroenterol Hepatol; 2017 Jan; 15(1):103-112.e2. PubMed ID: 27311619
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced autoimmune hepatitis: A minireview.
Tan CK; Ho D; Wang LM; Kumar R
World J Gastroenterol; 2022 Jun; 28(24):2654-2666. PubMed ID: 35979160
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune-like drug-induced liver injury: a review and update for the clinician.
Stine JG; Northup PG
Expert Opin Drug Metab Toxicol; 2016 Nov; 12(11):1291-1301. PubMed ID: 27402321
[TBL] [Abstract][Full Text] [Related]
8. Clinical presentation, causative drugs and outcome of patients with autoimmune features in two prospective DILI registries.
García-Cortés M; Ortega-Alonso A; Matilla-Cabello G; Medina-Cáliz I; Castiella A; Conde I; Bonilla-Toyos E; Pinazo-Bandera J; Hernández N; Tagle M; Nunes V; Parana R; Bessone F; Kaplowitz N; Lucena MI; Alvarez-Alvarez I; Robles-Díaz M; Andrade RJ
Liver Int; 2023 Aug; 43(8):1749-1760. PubMed ID: 37269163
[TBL] [Abstract][Full Text] [Related]
9. The Epidemiology of Newly Recognized Causes of Drug-Induced Liver Injury: An Update.
Björnsson ES
Pharmaceuticals (Basel); 2024 Apr; 17(4):. PubMed ID: 38675480
[TBL] [Abstract][Full Text] [Related]
10. Defining characteristics and long-term prognosis of drug-induced autoimmune-like hepatitis: A retrospective cohort study.
Chung Y; Morrison M; Zen Y; Heneghan MA
United European Gastroenterol J; 2024 Feb; 12(1):66-75. PubMed ID: 38041550
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced liver injury with autoimmune features.
deLemos AS; Foureau DM; Jacobs C; Ahrens W; Russo MW; Bonkovsky HL
Semin Liver Dis; 2014 May; 34(2):194-204. PubMed ID: 24879983
[TBL] [Abstract][Full Text] [Related]
12. Infliximab-induced autoimmune hepatitis.
Jenkins A; Austin A; Hughes K; Sadowski B; Torres D
BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 34031069
[TBL] [Abstract][Full Text] [Related]
13. Drug-induced autoimmune hepatitis: clinical characteristics and prognosis.
Björnsson E; Talwalkar J; Treeprasertsuk S; Kamath PS; Takahashi N; Sanderson S; Neuhauser M; Lindor K
Hepatology; 2010 Jun; 51(6):2040-8. PubMed ID: 20512992
[TBL] [Abstract][Full Text] [Related]
14. Early ALT response to corticosteroid treatment distinguishes idiosyncratic drug-induced liver injury from autoimmune hepatitis.
Weber S; Benesic A; Rotter I; Gerbes AL
Liver Int; 2019 Oct; 39(10):1906-1917. PubMed ID: 31319011
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological Study of Autoimmune Hepatitis Cases That Were Difficult to Differentiate from Drug-Induced Liver Injury.
Tsutsui A; Harada K; Tsuneyama K; Senoh T; Nagano T; Takaguchi K; Ando M; Nakamura S; Mizobuchi K; Kudo M
Dig Dis; 2017; 35(6):506-514. PubMed ID: 29040982
[TBL] [Abstract][Full Text] [Related]
16. An analysis of drug-induced liver injury, which showed histological findings similar to autoimmune hepatitis.
Hisamochi A; Kage M; Ide T; Arinaga-Hino T; Amano K; Kuwahara R; Ogata K; Miyajima I; Kumashiro R; Sata M; Torimura T
J Gastroenterol; 2016 Jun; 51(6):597-607. PubMed ID: 26519284
[TBL] [Abstract][Full Text] [Related]
17. [Serological and pathological features of drug-induced liver injury and autoimmune hepatitis].
Jiang ZL; Li P; Wang JL; Yang QH; Liu YG; Shi RF; Mi YQ
Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):810-816. PubMed ID: 27978925
[No Abstract] [Full Text] [Related]
18. Drug-induced autoimmune liver disease: A diagnostic dilemma of an increasingly reported disease.
Castiella A; Zapata E; Lucena MI; Andrade RJ
World J Hepatol; 2014 Apr; 6(4):160-8. PubMed ID: 24799984
[TBL] [Abstract][Full Text] [Related]
19. A new framework for advancing in drug-induced liver injury research. The Prospective European DILI Registry.
Björnsson ES; Stephens C; Atallah E; Robles-Diaz M; Alvarez-Alvarez I; Gerbes A; Weber S; Stirnimann G; Kullak-Ublick G; Cortez-Pinto H; Grove JI; Lucena MI; Andrade RJ; Aithal GP
Liver Int; 2023 Jan; 43(1):115-126. PubMed ID: 35899490
[TBL] [Abstract][Full Text] [Related]
20. "Autoimmune(-Like)" Drug and Herb Induced Liver Injury: New Insights into Molecular Pathogenesis.
Sebode M; Schulz L; Lohse AW
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28895915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]